Dupilumab treatment for atopic dermatitis is associated with decreased utilization of psychostimulants for attention deficit hyperactivity disorder

Our study suggests that dupilumab treatment for AD is negatively correlated with the utilization of psychostimulants for ADHD本研究表明，针对特应性皮炎（Atopic Dermatitis，AD）的度普利尤单抗（dupilumab）治疗方案，与注意缺陷多动障碍（Attention Deficit Hyperactivity Disorder，ADHD）患者的精神兴奋剂（psychostimulants）使用量呈负相关。